Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/1539
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorSTEIN, Anna-
dc.contributor.authorGOLDMEIER, Silvia-
dc.contributor.authorVOLTOLINI, Sarah-
dc.contributor.authorSETOGUTTI, Enio-
dc.contributor.authorFELDMAN, Carlos-
dc.contributor.authorFIGUEIREDO, Eduardo-
dc.contributor.authorEICK, Renato-
dc.contributor.authorIRIGOYEN, Maria-
dc.contributor.authorRIGATTO, Katya-
dc.date.accessioned2013-07-30T17:52:41Z-
dc.date.available2013-07-30T17:52:41Z-
dc.date.issued2012-
dc.identifier.citationCLINICS, v.67, n.7, p.761-765, 2012-
dc.identifier.issn1807-5932-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/1539-
dc.description.abstractOBJECTIVE: The association between renal hypoxia and the development of renal injury is well established. However, no adequate method currently exists to non-invasively measure functional changes in renal oxygenation in normal and injured patients. METHOD: R2(star) quantification was performed using renal blood oxygen level-dependent properties. Five healthy normotensive women (50 +/- 5.3 years) underwent magnetic resonance imaging in a 1.5T Signa Excite HDx scanner (GE Healthcare, Waukesha, WI). A multiple fast gradient-echo sequence was used to acquire R2(star)/T-2(star) images (sixteen echoes from 2.1 ms/slice to 49.6 ms/slice in a single breath hold per location). The images were post-processed to generate R2(star) maps for quantification. Data were recorded before and at 30 minutes after the oral administration of an angiotensin II-converting enzyme inhibitor (captopril, 25 mg). The results were compared using an ANOVA for repeated measurements (mean +/- standard deviation) followed by the Tukey test. ClinicalTrials.gov: NCT01545479. RESULTS: A significant difference (p<0.001) in renal oxygenation (R2(star)) was observed in the cortex and medulla before and after captopril administration: right kidney, cortex = 11.08 +/- 0.56ms, medulla = 17.21 +/- 1.47ms and cortex = 10.30 +/- 0.44ms, medulla = 16.06 +/- 1.74ms, respectively; and left kidney, cortex = 11.79 +/- 1.85ms, medulla = 17.03 +/- 0.88ms and cortex = 10.89 +/- 0.91ms, medulla = 16.43 +/- 1.49ms, respectively. CONCLUSIONS: This result suggests that the technique efficiently measured alterations in renal blood oxygenation after angiotensin II-converting enzyme inhibition and that it may provide a new strategy for identifying the early stages of renal disease and perhaps new therapeutic targets.-
dc.language.isoeng-
dc.publisherHOSPITAL CLINICAS, UNIV SAO PAULO-
dc.relation.ispartofClinics-
dc.rightsopenAccess-
dc.subjectBOLD-
dc.subjectRenal Oxygenation-
dc.subjectHealthy Subjects-
dc.subjectCaptopril-
dc.subjectRenin-Angiotensin System-
dc.subject.otherchronic kidney-disease-
dc.subject.otherbold-mri-
dc.subject.otherwater diuresis-
dc.subject.othertubulointerstitial injury-
dc.subject.otherintrarenal oxygenation-
dc.subject.othermedullary oxygenation-
dc.subject.othermagnetic-resonance-
dc.subject.othertissue angiotensin-
dc.subject.otherchronic hypoxia-
dc.subject.otherprevention-
dc.titleRenal oxygen content is increased in healthy subjects after angiotensin-converting enzyme inhibition-
dc.typearticle-
dc.rights.holderCopyright HOSPITAL CLINICAS, UNIV SAO PAULO-
dc.identifier.doi10.6061/clinics/2012(07)10-
dc.identifier.pmid22892920-
dc.subject.wosMedicine, General & Internal-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.author.externalSTEIN, Anna:Fundacao Univ Cardiol IC FUC, Inst Cardiol Rio Grande do Sul, Porto Alegre, RS, Brazil; Univ Fed Sao Paulo UNIFESP, Sao Paulo, Brazil-
hcfmusp.author.externalGOLDMEIER, Silvia:Fundacao Univ Cardiol IC FUC, Inst Cardiol Rio Grande do Sul, Porto Alegre, RS, Brazil-
hcfmusp.author.externalVOLTOLINI, Sarah:Fundacao Univ Cardiol IC FUC, Inst Cardiol Rio Grande do Sul, Porto Alegre, RS, Brazil-
hcfmusp.author.externalSETOGUTTI, Enio:Serv Invest Diagnost SIDI, Porto Alegre, RS, Brazil-
hcfmusp.author.externalFELDMAN, Carlos:Fundacao Univ Cardiol IC FUC, Inst Cardiol Rio Grande do Sul, Porto Alegre, RS, Brazil; Serv Invest Diagnost SIDI, Porto Alegre, RS, Brazil-
hcfmusp.author.externalFIGUEIREDO, Eduardo:MR Res Latin Amer GE Healthcare, Sao Paulo, Brazil-
hcfmusp.author.externalEICK, Renato:Fundacao Univ Cardiol IC FUC, Inst Cardiol Rio Grande do Sul, Porto Alegre, RS, Brazil-
hcfmusp.author.externalRIGATTO, Katya:UFCSPA, Dept Ciencias Basicas Saude, Porto Alegre, RS, Brazil-
hcfmusp.description.beginpage761-
hcfmusp.description.endpage765-
hcfmusp.description.issue7-
hcfmusp.description.volume67-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-84867069551-
hcfmusp.origem.idWOS:000307723100010-
hcfmusp.origem.idSCIELO:S1807-59322012000700010-
hcfmusp.publisher.citySAO PAULO-
hcfmusp.publisher.countryBRAZIL-
hcfmusp.relation.referenceAlcazar JM, 2000, AM J KIDNEY DIS, V36, P883, DOI 10.1053/ajkd.2000.19077-
hcfmusp.relation.referenceBadzynska B, 2008, EXP PHYSIOL, V93, P1292, DOI 10.1113/expphysiol.2008.043604-
hcfmusp.relation.referenceBello AK, 2005, KIDNEY INT, V68, pS11, DOI 10.1111/j.1523-1755.2005.09802.x-
hcfmusp.relation.referenceBLANTZ RC, 1976, J CLIN INVEST, V57, P419, DOI 10.1172/JCI108293-
hcfmusp.relation.referenceBRENNER BM, 1982, CONTRIB NEPHROL, V33, P48-
hcfmusp.relation.referenceBrosius FC, 2006, HYPERTENSION, V48, P751-
hcfmusp.relation.referenceChen SX, 2008, EUR J PHARMACOL, V584, P368, DOI 10.1016/j.ejphar.2008.02.020-
hcfmusp.relation.referenceChrysochou C, 2012, NEPHROL DIAL TRANSPL, V27, P1013, DOI 10.1093/ndt/gfr392-
hcfmusp.relation.referenceDzau VJ, 2001, HYPERTENSION, V37, P1047-
hcfmusp.relation.referenceEpstein FH, 2000, KIDNEY INT, V57, P2080, DOI 10.1046/j.1523-1755.2000.00057.x-
hcfmusp.relation.referenceEpstein FH, 2002, DIABETES CARE, V25, P575, DOI 10.2337/diacare.25.3.575-
hcfmusp.relation.referenceGloviczki ML, CURRENT HYPERTENSION, V370- 7-
hcfmusp.relation.referenceHALL JE, 1983, AM J PHYSIOL, V245, pR166-
hcfmusp.relation.referenceHEYMAN SN, 1991, KIDNEY INT, V40, P632, DOI 10.1038/ki.1991.255-
hcfmusp.relation.referenceHofmann L, 2006, KIDNEY INT, V70, P144, DOI 10.1038/sj.ki.5000418-
hcfmusp.relation.referenceImig JD, 2000, AM J HYPERTENS, V13, P810, DOI 10.1016/S0895-7061(00)00264-8-
hcfmusp.relation.referenceJOHNSTON CI, 1994, HYPERTENSION, V23, P258-
hcfmusp.relation.referenceJuillard L, 2004, KIDNEY INT, V65, P944, DOI 10.1111/j.1523-1755.2004.00469.x-
hcfmusp.relation.referenceKellerman PS, 1996, SEMIN NEPHROL, V16, P33-
hcfmusp.relation.referenceKondo N, 2006, J PHARMACOL EXP THER, V316, P1047, DOI 10.1124/jpet.105.095331-
hcfmusp.relation.referenceMATTSON DL, 1992, HYPERTENSION, V19, P766-
hcfmusp.relation.referenceMehta RL, 2003, J AM SOC NEPHROL, V14, P2178, DOI 10.1097/01.ASN.0000079042.13465.1A-
hcfmusp.relation.referenceNangaku M, 2004, INTERNAL MED, V43, P9, DOI 10.2169/internalmedicine.43.9-
hcfmusp.relation.referenceNangaku M, 2007, ADV EXP MED BIOL, V618, P85-
hcfmusp.relation.referenceNangaku M, 2008, HYPERTENS RES, V31, P175, DOI 10.1291/hypres.31.175-
hcfmusp.relation.referenceNangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757-
hcfmusp.relation.referenceNavar LG, 1996, PHYSIOL REV, V76, P425-
hcfmusp.relation.referencePrasad P, 2010, INVEST RADIOL, V45, P819, DOI 10.1097/RLI.0b013e3181ec9b02-
hcfmusp.relation.referencePrasad PV, 1997, JMRI-J MAGN RESON IM, V7, P1163, DOI 10.1002/jmri.1880070633-
hcfmusp.relation.referencePrasad PV, 1999, KIDNEY INT, V55, P294, DOI 10.1046/j.1523-1755.1999.00237.x-
hcfmusp.relation.referencePrasad PV, 1996, CIRCULATION, V94, P3271-
hcfmusp.relation.referenceRies M, 2003, J MAGN RESON IMAGING, V17, P104, DOI 10.1002/jmri.10224-
hcfmusp.relation.referenceSadowski EA, 2005, RADIOLOGY, V236, P911, DOI 10.1148/radiol.2363041080-
hcfmusp.relation.referenceSchachinger H, 2006, HYPERTENSION, V47, P1062, DOI 10.1161/01.HYP.0000220109.98142.a3-
hcfmusp.relation.referenceSchachinger H, 2004, J HYPERTENS, V22, P175, DOI 10.1097/01.hjh.0000098198.36890.31-
hcfmusp.relation.referenceSimon-Zoula SC, 2006, NMR BIOMED, V19, P84, DOI 10.1002/nbm.1004-
hcfmusp.relation.referenceSolski LV, 2008, AM J HEALTH-SYST PH, V65, P935, DOI 10.2146/ajhp070388-
hcfmusp.relation.referenceTextor SC, 2008, J AM SOC NEPHROL, V19, P780, DOI 10.1681/ASN.2007040420-
hcfmusp.relation.referenceWang Ta-Min, 2004, Chang Gung Med J, V27, P344-
hcfmusp.relation.referenceZuo CS, 2003, J MAGN RESON IMAGING, V17, P676, DOI 10.1002/jmri.10314-
dc.description.indexMEDLINE-
hcfmusp.citation.scopus6-
hcfmusp.scopus.lastupdate2024-04-12-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - HC/InCor
Instituto do Coração - HC/InCor

Artigos e Materiais de Revistas Científicas - LIM/59
LIM/59 - Laboratório de Biologia Celular


Files in This Item:
File Description SizeFormat 
art_IRIGOYEN_Renal_oxygen_content_is_increased_in_healthy_subjects_2012.PDFpublishedVersion (English)649.72 kBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.